UBX RSI Chart
Last 7 days
4.7%
Last 30 days
-19.5%
Last 90 days
-1.9%
Trailing 12 Months
-58.5%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2022 | 3.6M | 2.5M | 1.4M | 236.0K |
2021 | 0 | 0 | 0 | 4.8M |
2017 | 0 | 0 | 0 | 1.4M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 26, 2024 | nguyen alexander hieu | acquired | - | - | 20,000 | chief legal officer |
Feb 02, 2024 | ghosh anirvan | sold | -1,162 | 1.71 | -680 | chief executive officer |
Jan 30, 2024 | ghosh anirvan | sold | -2,022 | 1.71 | -1,183 | chief executive officer |
Nov 02, 2023 | ghosh anirvan | sold | -1,077 | 1.83 | -589 | chief executive officer |
Oct 30, 2023 | ghosh anirvan | sold | -1,945 | 1.9 | -1,024 | chief executive officer |
Sep 14, 2023 | ghosh anirvan | sold | -3,077 | 2.47 | -1,246 | chief executive officer |
Aug 02, 2023 | ghosh anirvan | sold | -1,708 | 2.94 | -581 | chief executive officer |
Jul 31, 2023 | ghosh anirvan | sold | -2,917 | 2.86 | -1,020 | chief executive officer |
Jun 26, 2023 | ghosh anirvan | sold | -3,766 | 3.2 | -1,177 | chief executive officer |
Jun 14, 2023 | ghosh anirvan | sold | -4,108 | 3.39 | -1,212 | chief executive officer |
Which funds bought or sold UBX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 11, 2024 | VANGUARD GROUP INC | unchanged | - | -263,953 | 1,083,890 | -% |
Feb 15, 2024 | JANE STREET GROUP, LLC | added | 66.45 | 13,890 | 54,918 | -% |
Feb 14, 2024 | CITADEL ADVISORS LLC | new | - | 93,945 | 93,945 | -% |
Feb 14, 2024 | AllSquare Wealth Management LLC | unchanged | - | -26.00 | 106 | -% |
Feb 14, 2024 | Royal Bank of Canada | reduced | -75.91 | -3,000 | 1,000 | -% |
Feb 14, 2024 | Ameritas Investment Partners, Inc. | unchanged | - | -47.00 | 193 | -% |
Feb 14, 2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | unchanged | - | -23,500 | 96,500 | -% |
Feb 14, 2024 | UBS OCONNOR LLC | reduced | -48.24 | -250,881 | 178,911 | 0.01% |
Unveiling UNITY Biotechnology Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to UNITY Biotechnology Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 42.3B | 6.8B | -8.96 | 6.17 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 19.4B | 1.8B | -44.17 | 10.64 | ||||
BMRN | 16.7B | 2.4B | 99.73 | 6.91 | ||||
INCY | 12.8B | 3.7B | 21.46 | 3.47 | ||||
MID-CAP | ||||||||
APLS | 7.1B | 396.6M | -13.34 | 17.78 | ||||
BBIO | 5.4B | - | -8.31 | 60.35 | ||||
AXSM | 3.8B | 270.6M | -15.68 | 13.86 | ||||
ARWR | 3.6B | 240.7M | -11.98 | 14.77 | ||||
ACAD | 3.0B | 726.4M | -48.93 | 4.13 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 398.2M | 26.85 | 4.82 | ||||
NVAX | 678.8M | 983.7M | -1.25 | 0.69 | ||||
CRBP | 373.2M | 881.7K | -8.37 | 466.16 | ||||
INO | 304.5M | 4.9M | -2.25 | 62.57 | ||||
IBIO | 11.8M | 2.1M | -0.43 | 2.14 |
UNITY Biotechnology Inc News
Income Statement (Quarterly) | |||||||
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2017Q4 |
Revenue | - | - | - | 236 | - | - | - |
Operating Expenses | 6.0% | 13,917 | 13,130 | 12,494 | 18,267 | 14,682 | 14,169 |
S&GA Expenses | 7.3% | 5,280 | 4,922 | 4,941 | 5,806 | 5,104 | 2,578 |
R&D Expenses | 5.2% | 8,637 | 8,208 | 7,553 | 12,461 | 9,579 | 11,591 |
Interest Expenses | 14.3% | 990 | 866 | 894 | 808 | 826 | - |
Net Income | -3.4% | -14,168 | -13,708 | -13,137 | -18,915 | -10,693 | -12,544 |
Net Income Margin | -517.6% | -253.93* | -41.12* | -23.58* | -17.52* | -12.69* | - |
Free Cashflow | 4.6% | -10,403 | -10,904 | -14,846 | -14,972 | -5,067 | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | -31.4% | 69.00 | 101 | 114 | 124 | 136 | 98.00 | 112 | 125 | 126 | 136 | 148 | 156 | 175 | 165 | 158 | 151 | 142 | 154 | 161 | 181 | 195 |
Current Assets | -32.1% | 50.00 | 73.00 | 86.00 | 97.00 | 103 | 68.00 | 81.00 | 91.00 | 85.00 | 88.00 | 102 | 101 | 136 | 124 | 115 | 129 | 126 | 141 | 152 | 173 | 180 |
Cash Equivalents | -58.8% | 8.00 | 19.00 | 23.00 | 13.00 | 23.00 | 19.00 | 16.00 | 34.00 | 22.00 | 13.00 | 27.00 | 18.00 | 50.00 | 41.00 | 27.00 | 39.00 | 38.00 | 25.00 | 36.00 | 16.00 | 29.00 |
Net PPE | -26.0% | 5.00 | 7.00 | 7.00 | 8.00 | 8.00 | 9.00 | 9.00 | 10.00 | 11.00 | 11.00 | 12.00 | 13.00 | 14.00 | 14.00 | 15.00 | 17.00 | 5.00 | 6.00 | 6.00 | 6.00 | 6.00 |
Liabilities | -35.9% | 33.00 | 52.00 | 56.00 | 58.00 | 58.00 | 58.00 | 62.00 | 65.00 | 68.00 | 70.00 | 68.00 | 73.00 | 77.00 | 52.00 | 52.00 | 31.00 | 27.00 | 27.00 | 14.00 | 21.00 | 15.00 |
Current Liabilities | -61.2% | 9.00 | 22.00 | 22.00 | 20.00 | 17.00 | 16.00 | 18.00 | 17.00 | 13.00 | 13.00 | 10.00 | 14.00 | 17.00 | 16.00 | 15.00 | 17.00 | 14.00 | 15.00 | 11.00 | 17.00 | 12.00 |
Long Term Debt | -100.0% | - | 4.00 | 8.00 | 11.00 | 13.00 | 13.00 | 15.00 | 18.00 | 24.00 | 25.00 | 25.00 | 25.00 | 24.00 | - | - | - | - | - | - | - | - |
LT Debt, Current | -100.0% | - | 14.00 | 13.00 | 9.00 | 7.00 | 7.00 | 5.00 | 3.00 | 1.00 | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | -100.0% | - | 4.00 | 8.00 | 11.00 | 13.00 | 13.00 | 15.00 | 18.00 | 24.00 | 25.00 | 25.00 | 25.00 | 24.00 | - | - | - | - | - | - | - | - |
Shareholder's Equity | -26.7% | 36.00 | 49.00 | 59.00 | 67.00 | 79.00 | 40.00 | 51.00 | 60.00 | 58.00 | 66.00 | 80.00 | 83.00 | 98.00 | 112 | 105 | 121 | 115 | 127 | 147 | 161 | 180 |
Retained Earnings | -3.2% | -498 | -483 | -470 | -459 | -445 | -432 | -418 | -400 | -389 | -372 | -355 | -339 | -319 | -292 | -273 | -245 | -227 | -205 | -182 | -163 | -141 |
Additional Paid-In Capital | 0.4% | 535 | 533 | 530 | 527 | 525 | 472 | 470 | 460 | 447 | 439 | 435 | 422 | 418 | 405 | 379 | 367 | 343 | 333 | 329 | 325 | 322 |
Shares Outstanding | 0.1% | 15.00 | 15.00 | 14.00 | 14.00 | 10.00 | 7.00 | 7.00 | 6.00 | 5.00 | 5.00 | 5.00 | 5.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | - | - | 33.00 | - | - | - | 202 | - | - | - | 326 | - | - | - | 277 | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | 36.0% | -7,101 | -11,099 | -11,300 | -10,366 | -10,856 | -14,835 | -14,972 | -5,060 | -11,525 | -13,375 | -15,100 | -16,714 | -17,219 | -19,327 | -25,073 | -15,721 | -16,800 | -19,304 | -20,596 | -12,806 | -13,885 |
Share Based Compensation | -13.0% | 2,055 | 2,361 | 2,270 | 2,259 | 2,210 | 2,250 | 2,660 | 2,941 | 3,086 | 2,782 | 2,744 | 2,700 | 3,692 | 4,104 | 3,317 | 3,088 | 3,823 | 1,944 | 1,997 | 2,516 | 2,717 |
Cashflow From Investing | 44.6% | 14,249 | 9,854 | 21,278 | -191 | -36,230 | 17,693 | -5,817 | 9,078 | 17,152 | -979 | 14,062 | -14,575 | -6,608 | 12,309 | 3,666 | -4,472 | 25,081 | 7,284 | 40,060 | -989 | 8,628 |
Cashflow From Financing | -600.1% | -18,377 | -2,625 | 274 | 167 | 50,220 | 138 | 4,330 | 6,862 | 2,900 | 1,019 | 10,064 | 515 | 32,859 | 21,508 | 8,993 | 20,868 | 5,407 | 881 | 282 | 297 | -11.00 |
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||||
---|---|---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |||
Statement of Comprehensive Income [Abstract] | ||||||
Licensing revenue - related party | $ 236 | |||||
Operating expenses: | ||||||
Research and development | $ 4,901 | $ 8,208 | $ 17,266 | 28,222 | ||
General and administrative | 4,428 | 4,922 | 14,681 | 15,669 | ||
Impairment of long-lived assets | 5,602 | 5,602 | 0 | |||
Total operating expenses | 14,931 | 13,130 | 37,549 | 43,891 | ||
Loss from operations | (14,931) | (13,130) | (37,549) | (43,655) | ||
Interest income | 689 | 329 | 2,349 | 416 | ||
Interest expense | (470) | (866) | (2,451) | (2,568) | ||
Other income (expense), net | (577) | (41) | (711) | 49 | ||
Net loss | (15,289) | (13,708) | (38,362) | (45,758) | ||
Other comprehensive (loss) gain | ||||||
Unrealized gain (loss) on marketable debt securities | 81 | (88) | 196 | (231) | ||
Comprehensive loss | $ (15,208) | $ (13,796) | $ (38,166) | $ (45,989) | ||
Net loss per share, basic | $ (1.05) | $ (1.36) | $ (2.66) | $ (5.77) | ||
Net loss per share, diluted | $ (1.05) | $ (1.36) | $ (2.66) | $ (5.77) | ||
Weighted-average number of shares used in computing net loss per share, basic | [1] | 14,598,218 | 10,072,077 | 14,446,672 | 7,928,729 | |
Weighted-average number of shares used in computing net loss per share, diluted | [1] | 14,598,218 | 10,072,077 | 14,446,672 | 7,928,729 | |
|
Condensed Balance Sheets (Unaudited) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 | |||||
---|---|---|---|---|---|---|---|
Current assets: | |||||||
Cash and cash equivalents | $ 7,876 | $ 12,736 | [1] | ||||
Short-term marketable securities | 38,063 | 82,059 | [1] | ||||
Prepaid expenses and other current assets | 3,599 | 1,740 | [1] | ||||
Total current assets | 49,538 | 96,535 | [1] | ||||
Property and equipment, net | 5,314 | 7,825 | [1] | ||||
Operating lease right-of-use assets | 13,522 | 19,042 | [1] | ||||
Long-term restricted cash | 896 | 896 | [1] | ||||
Other long-term assets | 0 | 52 | [1] | ||||
Total assets | 69,270 | 124,350 | [1] | ||||
Current liabilities: | |||||||
Accounts payable | 1,149 | 1,790 | [1] | ||||
Accrued compensation | 2,226 | 3,020 | [1] | ||||
Accrued and other current liabilities | 5,258 | 5,334 | [1] | ||||
Current portion of long-term debt | 0 | 9,476 | [1] | ||||
Total current liabilities | 8,633 | 19,620 | [1] | ||||
Operating lease liability, net of current portion | 24,431 | 26,991 | [1] | ||||
Long-term debt, net of current portion | 0 | 10,891 | [1] | ||||
Total liabilities | 33,064 | 57,502 | [1] | ||||
Commitments and contingencies (Note 8) | |||||||
Stockholders’ equity: | |||||||
Convertible preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding | 0 | 0 | [1] | ||||
Common stock, $0.0001 par value; 300,000,000 shares authorized as of September 30, 2023 and December 31, 2022; 14,614,890 and 14,215,302 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively | [2] | 1 | 1 | [1] | |||
Additional paid-in capital | 534,570 | 527,049 | [1] | ||||
Accumulated other comprehensive loss | (55) | (251) | [1] | ||||
Accumulated deficit | (498,310) | (459,951) | [1] | ||||
Total stockholders’ equity | 36,206 | 66,848 | [1] | ||||
Total liabilities and stockholders’ equity | $ 69,270 | $ 124,350 | [1] | ||||
|